Literature DB >> 17367092

Patterns of illicit drug use and retention in a methadone program: a longitudinal study.

Ingrid Davstad1, Marlene Stenbacka, Anders Leifman, Olof Beck, Seher Korkmaz, Anders Romelsjö.   

Abstract

OBJECTIVE: This study aimed to analyze illicit drug use of participants in a methadone treatment program in relation to methadone dose, counseling, and retention.
METHODS: This was a longitudinal study of a cohort of 204 heroin-dependent subjects admitted for the first time to a methadone program in Stockholm. The patients were admitted between 1995 and mid-2000 and were followed until December 2000 or discharge. Up to June 11, 1998, individual psychosocial counseling was provided; after this date individual counseling was replaced with group counseling. Clinical data were collected from patient records and from a laboratory database. Rates of drug-positive urine analyses during different time periods were measured.
RESULTS: The mean observation time was 2.5 years for all patients. The one-year retention rate was 84 percent, and the two-year rate was 65 percent, with no major differences between the two counseling groups. Almost all patients relapsed to illicit drug use. Discharged patients had a significantly higher rate of positive urine samples (21 percent versus 9 percent) than patients who remained in treatment. Also, low methadone dose and younger age predicted discharge from treatment.
CONCLUSION: The frequent urine monitoring showed that illicit drug use was rather common, even in a program with structured psychosocial interventions, although it was lower than in other studies. This testing policy can be used for early identification of patients at risk for drop-out or discharge who should be offered complementary interventions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17367092     DOI: 10.5055/jom.2007.0036

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  17 in total

1.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

Review 2.  Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?

Authors:  Maria Paz Garcia-Portilla; Maria Teresa Bobes-Bascaran; Maria Teresa Bascaran; Pilar Alejandra Saiz; Julio Bobes
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

3.  Pharmacotherapy in the treatment of addiction: methadone.

Authors:  Mary Jeanne Kreek; Lisa Borg; Elizabeth Ducat; Brenda Ray
Journal:  J Addict Dis       Date:  2010-04

4.  Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States.

Authors:  Alexei Zelenev; Jianghong Li; Portia Shea; Robert Hecht; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

5.  Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years.

Authors:  Yih-Ing Hser; Elizabeth Evans; David Huang; Mary-Lynn Brecht; Libo Li
Journal:  Addict Behav       Date:  2008-08-08       Impact factor: 3.913

6.  Predictors of dropout from psychosocial treatment in opioid-dependent outpatients.

Authors:  R Kathryn McHugh; Heather W Murray; Bridget A Hearon; Elizabeth M Pratt; Mark H Pollack; Steven A Safren; Michael W Otto
Journal:  Am J Addict       Date:  2013-01

Review 7.  Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.

Authors:  Reda M Chalhoub; Peter W Kalivas
Journal:  Drugs       Date:  2020-10       Impact factor: 9.546

8.  Gender Differences in Patterns and Correlates of Continued Substance Use among Patients in Methadone Maintenance Treatment.

Authors:  Tomorrow D Arnold; Lewei Allison Lin; Brandi P Cotton; William C Bryson; Courtney A Polenick
Journal:  Subst Use Misuse       Date:  2021-03-01       Impact factor: 2.164

9.  Methadone treatments in a Swiss region, 2001-2008: a registry-based analysis.

Authors:  Thérèse Huissoud; Valentin Rousson; Françoise Dubois-Arber
Journal:  BMC Psychiatry       Date:  2012-12-28       Impact factor: 3.630

Review 10.  Cortico-striatal circuits: Novel therapeutic targets for substance use disorders.

Authors:  Alexxai V Kravitz; Dardo Tomasi; Kimberly H LeBlanc; Ruben Baler; Nora D Volkow; Antonello Bonci; Sergi Ferré
Journal:  Brain Res       Date:  2015-04-09       Impact factor: 3.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.